Durán, Josefina <br/><br/>
Why methotrexate suboptimal dosing is a potential source of bias in biologic drugs clinical trials.  [electronic resource] 

 -  Annals of the rheumatic diseases  08 2016 
 - e53 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/annrheumdis-2016-209791  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antirheumatic Agents<br/>Arthritis, Rheumatoid<br/>Biological Products<br/>Humans<br/>Methotrexate